Cas No.: | 1675203-84-5 |
Chemical Name: | N-[2-[[[2-methoxy-6-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]-3-pyridinyl]methyl]amino]ethyl]-acetamide |
Synonyms: | PD-L1 inhibitor 2,PD-1 inhibitor 2,PD1 inhibitor 2,PD 1 inhibitor 2,BMS 202,BMS202 |
SMILES: | C(NCCNCC1=CC=C(OCC2C=CC=C(C3=CC=CC=C3)C=2C)N=C1OC)(=O)C |
Formula: | C25H29N3O3 |
M.Wt: | 419.52 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | BMS-202 is an inhibitor of the PD-1/PD-L1 protein/protein interaction with an IC50 of 18 nM. |
In Vitro: | BMS-202 inhibits PD-1/PD-Ll interaction, and may augment therapeutic immune response to a number of histologically distinct tumors. Blockade of the PD-1/PD-Ll ligation using antibodies to PD-Ll has been shown to restore and augment T cell activation in many systems[1]. |